The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-1-(4,7-dihydro-5H-thieno[2,3-c]pyran-7-yl)-N,N-dimethylmethanamine ID: ALA5094071
PubChem CID: 166631571
Max Phase: Preclinical
Molecular Formula: C10H15NOS
Molecular Weight: 197.30
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)C[C@@H]1OCCc2ccsc21
Standard InChI: InChI=1S/C10H15NOS/c1-11(2)7-9-10-8(3-5-12-9)4-6-13-10/h4,6,9H,3,5,7H2,1-2H3/t9-/m0/s1
Standard InChI Key: YMIRSMZJILLWTJ-VIFPVBQESA-N
Molfile:
RDKit 2D
13 14 0 0 0 0 0 0 0 0999 V2000
11.4739 -22.1191 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.4739 -22.9477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1889 -23.3578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1889 -21.7007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9039 -22.1191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9085 -22.9441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6945 -23.1947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1757 -22.5247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6872 -21.8600 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.1889 -20.8722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4713 -20.4579 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4713 -19.6294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7538 -20.8722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 1 0
2 3 1 0
3 6 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
4 10 1 1
10 11 1 0
11 12 1 0
11 13 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 197.30Molecular Weight (Monoisotopic): 197.0874AlogP: 1.92#Rotatable Bonds: 2Polar Surface Area: 12.47Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.06CX LogP: 1.88CX LogD: 1.13Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.72Np Likeness Score: -1.19
References 1. Heffernan MLR, Herman LW, Brown S, Jones PG, Shao L, Hewitt MC, Campbell JE, Dedic N, Hopkins SC, Koblan KS, Xie L.. (2022) Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia., 13 (1.0): [PMID:35047111 ] [10.1021/acsmedchemlett.1c00527 ]